Axim Biotechnologies Stock Technical Analysis

AXIM Stock  USD 0.01  0  26.67%   
As of the 30th of January, Axim Biotechnologies shows the Risk Adjusted Performance of 0.103, mean deviation of 9.18, and Downside Deviation of 13.4. Axim Biotechnologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Axim Biotechnologies information ratio, as well as the relationship between the potential upside and kurtosis to decide if Axim Biotechnologies is priced correctly, providing market reflects its regular price of 0.011 per share. As Axim Biotechnologies appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Axim Biotechnologies Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Axim, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Axim
  
Axim Biotechnologies' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Understanding that Axim Biotechnologies' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Axim Biotechnologies represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Axim Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Axim Biotechnologies 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Axim Biotechnologies' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Axim Biotechnologies.
0.00
11/01/2025
No Change 0.00  0.0 
In 3 months and 1 day
01/30/2026
0.00
If you would invest  0.00  in Axim Biotechnologies on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Axim Biotechnologies or generate 0.0% return on investment in Axim Biotechnologies over 90 days. Axim Biotechnologies is related to or competes with Zelira Therapeutics, and Sigyn Therapeutics. AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, an... More

Axim Biotechnologies Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Axim Biotechnologies' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Axim Biotechnologies upside and downside potential and time the market with a certain degree of confidence.

Axim Biotechnologies Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Axim Biotechnologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Axim Biotechnologies' standard deviation. In reality, there are many statistical measures that can use Axim Biotechnologies historical prices to predict the future Axim Biotechnologies' volatility.
Hype
Prediction
LowEstimatedHigh
0.000.0113.76
Details
Intrinsic
Valuation
LowRealHigh
0.000.0113.76
Details
Naive
Forecast
LowNextHigh
0.00030.0213.76
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.02
Details

Axim Biotechnologies January 30, 2026 Technical Indicators

Axim Biotechnologies Backtested Returns

Axim Biotechnologies is out of control given 3 months investment horizon. Axim Biotechnologies secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.77% are justified by taking the suggested risk. Use Axim Biotechnologies Risk Adjusted Performance of 0.103, downside deviation of 13.4, and Mean Deviation of 9.18 to evaluate company specific risk that cannot be diversified away. Axim Biotechnologies holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.24, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Axim Biotechnologies will likely underperform. Use Axim Biotechnologies total risk alpha and the relationship between the potential upside and period momentum indicator , to analyze future returns on Axim Biotechnologies.

Auto-correlation

    
  -0.52  

Good reverse predictability

Axim Biotechnologies has good reverse predictability. Overlapping area represents the amount of predictability between Axim Biotechnologies time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Axim Biotechnologies price movement. The serial correlation of -0.52 indicates that about 52.0% of current Axim Biotechnologies price fluctuation can be explain by its past prices.
Correlation Coefficient-0.52
Spearman Rank Test-0.21
Residual Average0.0
Price Variance0.0
Axim Biotechnologies technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Axim Biotechnologies technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Axim Biotechnologies trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Axim Biotechnologies Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Axim Biotechnologies volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Axim Biotechnologies Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Axim Biotechnologies on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Axim Biotechnologies based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Axim Biotechnologies price pattern first instead of the macroeconomic environment surrounding Axim Biotechnologies. By analyzing Axim Biotechnologies's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Axim Biotechnologies's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Axim Biotechnologies specific price patterns or momentum indicators. Please read more on our technical analysis page.

Axim Biotechnologies January 30, 2026 Technical Indicators

Most technical analysis of Axim help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Axim from various momentum indicators to cycle indicators. When you analyze Axim charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Axim Biotechnologies January 30, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Axim stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Other Information on Investing in Axim Pink Sheet

Axim Biotechnologies financial ratios help investors to determine whether Axim Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Axim with respect to the benefits of owning Axim Biotechnologies security.